Global CRISPR and CRISPR-Associated (Cas) Genes Market Insights and Forecast to 2031

Report ID: 1153949 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Genome Editing
        1.2.3 Genetic engineering
        1.2.4 gRNA Database/Gene Librar
        1.2.5 CRISPR Plasmid
        1.2.6 Human Stem Cells
        1.2.7 Genetically Modified Organisms/Crops
        1.2.8 Cell Line Engineering
    1.3 Market by Application
        1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Biotechnology Companies
        1.3.3 Pharmaceutical Companies
        1.3.4 Academic Institutes
        1.3.5 Research and Development Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2017-2028)
    2.2 CRISPR and CRISPR-Associated (Cas) Genes Growth Trends by Region
        2.2.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Region (2017-2022)
        2.2.3 CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2023-2028)
    2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
        2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
        2.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
        2.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
        2.3.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue
        3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2017-2022)
        3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2017-2022)
    3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
    3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio
        3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2021
    3.5 CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Area Served
    3.6 Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
    3.7 Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type
    4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2017-2022)
    4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2023-2028)
5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application
    5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2017-2022)
    5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
    6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
        6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
        6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
        6.2.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
    6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
        6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
        6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
        6.3.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
    6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
        6.4.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
        6.4.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
    7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
        7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
        7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
        7.2.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
    7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
        7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
        7.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
        7.3.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
    7.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
        7.4.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
        7.4.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
    8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
        8.2.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
    8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
        8.3.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
    8.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
        8.4.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
    9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
        9.2.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
        9.2.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
        9.2.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
    9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
        9.3.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
        9.3.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
        9.3.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
    9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
        9.4.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
        9.4.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
    10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
        10.2.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
    10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
        10.3.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
    10.4 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
        10.4.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Details
        11.1.2 Thermo Fisher Scientific Business Overview
        11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.1.5 Thermo Fisher Scientific Recent Developments
    11.2 Editas Medicine
        11.2.1 Editas Medicine Company Details
        11.2.2 Editas Medicine Business Overview
        11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.2.5 Editas Medicine Recent Developments
    11.3 Caribou Biosciences
        11.3.1 Caribou Biosciences Company Details
        11.3.2 Caribou Biosciences Business Overview
        11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.3.5 Caribou Biosciences Recent Developments
    11.4 CRISPR therapeutics
        11.4.1 CRISPR therapeutics Company Details
        11.4.2 CRISPR therapeutics Business Overview
        11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.4.5 CRISPR therapeutics Recent Developments
    11.5 Intellia therapeutics, Inc.
        11.5.1 Intellia therapeutics, Inc. Company Details
        11.5.2 Intellia therapeutics, Inc. Business Overview
        11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.5.5 Intellia therapeutics, Inc. Recent Developments
    11.6 Cellectis
        11.6.1 Cellectis Company Details
        11.6.2 Cellectis Business Overview
        11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.6.5 Cellectis Recent Developments
    11.7 Horizon Discovery Plc
        11.7.1 Horizon Discovery Plc Company Details
        11.7.2 Horizon Discovery Plc Business Overview
        11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.7.5 Horizon Discovery Plc Recent Developments
    11.8 Sigma Aldrich
        11.8.1 Sigma Aldrich Company Details
        11.8.2 Sigma Aldrich Business Overview
        11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.8.5 Sigma Aldrich Recent Developments
    11.9 Precision Biosciences
        11.9.1 Precision Biosciences Company Details
        11.9.2 Precision Biosciences Business Overview
        11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.9.5 Precision Biosciences Recent Developments
    11.10 Genscript
        11.10.1 Genscript Company Details
        11.10.2 Genscript Business Overview
        11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.10.5 Genscript Recent Developments
    11.11 Sangamo Biosciences Inc.
        11.11.1 Sangamo Biosciences Inc. Company Details
        11.11.2 Sangamo Biosciences Inc. Business Overview
        11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.11.5 Sangamo Biosciences Inc. Recent Developments
    11.12 Lonza Group Limited
        11.12.1 Lonza Group Limited Company Details
        11.12.2 Lonza Group Limited Business Overview
        11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.12.5 Lonza Group Limited Recent Developments
    11.13 Integrated DNA Technologies
        11.13.1 Integrated DNA Technologies Company Details
        11.13.2 Integrated DNA Technologies Business Overview
        11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.13.5 Integrated DNA Technologies Recent Developments
    11.14 New England Biolabs
        11.14.1 New England Biolabs Company Details
        11.14.2 New England Biolabs Business Overview
        11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.14.5 New England Biolabs Recent Developments
    11.15 Origene Technologies
        11.15.1 Origene Technologies Company Details
        11.15.2 Origene Technologies Business Overview
        11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
        11.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
        11.15.5 Origene Technologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Genome Editing
    Table 3. Key Players of Genetic engineering
    Table 4. Key Players of gRNA Database/Gene Librar
    Table 5. Key Players of CRISPR Plasmid
    Table 6. Key Players of Human Stem Cells
    Table 7. Key Players of Genetically Modified Organisms/Crops
    Table 8. Key Players of Cell Line Engineering
    Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2017-2022)
    Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2023-2028)
    Table 15. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
    Table 16. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
    Table 17. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
    Table 18. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
    Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Players (2017-2022)
    Table 21. Global Top CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2021)
    Table 22. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
    Table 26. Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2017-2022)
    Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2023-2028)
    Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Application (2017-2022)
    Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Application (2023-2028)
    Table 36. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
    Table 66. Thermo Fisher Scientific Company Details
    Table 67. Thermo Fisher Scientific Business Overview
    Table 68. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 69. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 70. Thermo Fisher Scientific Recent Developments
    Table 71. Editas Medicine Company Details
    Table 72. Editas Medicine Business Overview
    Table 73. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 74. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 75. Editas Medicine Recent Developments
    Table 76. Caribou Biosciences Company Details
    Table 77. Caribou Biosciences Business Overview
    Table 78. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 79. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 80. Caribou Biosciences Recent Developments
    Table 81. CRISPR therapeutics Company Details
    Table 82. CRISPR therapeutics Business Overview
    Table 83. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 84. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 85. CRISPR therapeutics Recent Developments
    Table 86. Intellia therapeutics, Inc. Company Details
    Table 87. Intellia therapeutics, Inc. Business Overview
    Table 88. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 89. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 90. Intellia therapeutics, Inc. Recent Developments
    Table 91. Cellectis Company Details
    Table 92. Cellectis Business Overview
    Table 93. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 94. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 95. Cellectis Recent Developments
    Table 96. Horizon Discovery Plc Company Details
    Table 97. Horizon Discovery Plc Business Overview
    Table 98. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 99. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 100. Horizon Discovery Plc Recent Developments
    Table 101. Sigma Aldrich Company Details
    Table 102. Sigma Aldrich Business Overview
    Table 103. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 104. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 105. Sigma Aldrich Recent Developments
    Table 106. Precision Biosciences Company Details
    Table 107. Precision Biosciences Business Overview
    Table 108. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 109. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 110. Precision Biosciences Recent Developments
    Table 111. Genscript Company Details
    Table 112. Genscript Business Overview
    Table 113. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 114. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 115. Genscript Recent Developments
    Table 116. Sangamo Biosciences Inc. Company Details
    Table 117. Sangamo Biosciences Inc. Business Overview
    Table 118. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 119. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 120. Sangamo Biosciences Inc. Recent Developments
    Table 121. Lonza Group Limited Company Details
    Table 122. Lonza Group Limited Business Overview
    Table 123. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 124. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 125. Lonza Group Limited Recent Developments
    Table 126. Integrated DNA Technologies Company Details
    Table 127. Integrated DNA Technologies Business Overview
    Table 128. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 129. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 130. Integrated DNA Technologies Recent Developments
    Table 131. New England Biolabs Company Details
    Table 132. New England Biolabs Business Overview
    Table 133. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 134. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 135. New England Biolabs Recent Developments
    Table 136. Origene Technologies Company Details
    Table 137. Origene Technologies Business Overview
    Table 138. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
    Table 139. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
    Table 140. Origene Technologies Recent Developments
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2021 VS 2028
    Figure 2. Genome Editing Features
    Figure 3. Genetic engineering Features
    Figure 4. gRNA Database/Gene Librar Features
    Figure 5. CRISPR Plasmid Features
    Figure 6. Human Stem Cells Features
    Figure 7. Genetically Modified Organisms/Crops Features
    Figure 8. Cell Line Engineering Features
    Figure 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2021 VS 2028
    Figure 10. Biotechnology Companies Case Studies
    Figure 11. Pharmaceutical Companies Case Studies
    Figure 12. Academic Institutes Case Studies
    Figure 13. Research and Development Institutes Case Studies
    Figure 14. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
    Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region: 2021 VS 2028
    Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2021
    Figure 19. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2021
    Figure 21. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
    Figure 23. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
    Figure 24. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Country (2017-2028)
    Figure 25. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
    Figure 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
    Figure 30. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Country (2017-2028)
    Figure 31. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Region (2017-2028)
    Figure 41. China CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Country (2017-2028)
    Figure 51. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Country (2017-2028)
    Figure 57. Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 61. Editas Medicine Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 62. Caribou Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 63. CRISPR therapeutics Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 64. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 65. Cellectis Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 66. Horizon Discovery Plc Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 67. Sigma Aldrich Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 68. Precision Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 69. Genscript Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 70. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 71. Lonza Group Limited Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 72. Integrated DNA Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 73. New England Biolabs Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 74. Origene Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Frequently Asked Questions
CRISPR and CRISPR-Associated (Cas) Genes report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CRISPR and CRISPR-Associated (Cas) Genes report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CRISPR and CRISPR-Associated (Cas) Genes report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports